Clinical Trials Logo

Keratoconjunctivitis Sicca clinical trials

View clinical trials related to Keratoconjunctivitis Sicca.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 6

NCT ID: NCT02992535 Not yet recruiting - Dry Eye Clinical Trials

Effect of Intense Pulse Light (IPL) Treatment on Tear Film Osmolarity

Start date: January 2017
Phase: Phase 4
Study type: Interventional

Evaluate changes in tear film osmolarity and other DED signs/symptoms following treatment with IPL.

NCT ID: NCT02782260 Not yet recruiting - Dry Eye Syndromes Clinical Trials

Assessment of the Efficacy of Ocular Dipyridamole in the Treatment of Dry Eye Symptomology in Subjects With Pterygium

Start date: July 2016
Phase: Phase 2
Study type: Interventional

Subjects with pterygium and associated dry eye symptoms (DES) are randomized into an active cohort (receiving ocular administration of Dipyridamole) or placebo cohort (ocular administration of vehicle). Monthly follow up is conducted for 12 months. Testing conducted at follow up will assess dry eye / pterygium symptoms and endpoints and review the efficacy of the intervention.

NCT ID: NCT02424266 Not yet recruiting - Healthy Subjects Clinical Trials

Three Dimension Tomography of Eye Structures by White Light Imaging Device

3D-WLT
Start date: April 2015
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of this study is to investigate the ability of an imaging device, developed by AdOM Advanced Optical Technologies Ltd. ("AdOM"). The device allows a three-dimensional imaging of the ocular tissues, specifically the tear film layers and the retinal layers. The device is based on the use of white light. In this initial study, the device will be used to assess the tear film which coats the corneal surface in healthy subjects as well as in moderate-to-severe Keratoconjunctivitis Sicca (KCS) or Dry Eye Syndrome (DES). The ability of the device to assess the retinal layers will be evaluated in the second phase of the study.

NCT ID: NCT02218827 Not yet recruiting - Dry Eye Clinical Trials

Topical Steroid Treatment For Dry Eye

Start date: September 2014
Phase: N/A
Study type: Interventional

Many patients refer to an oculoplastic or corneal clinic examination due to dry eye symptoms. epidemiologic studies estimate that as many as 15% of the population over 60 years suffer from dry eye. the disease can be treated both topically through several drugs or through mechanical closure of the lacrimal drainage system. in the past decade a few studies demonstrated the efficacy of anti inflammatory treatment on dry eye disease due to the inflammatory process that occurs in it. this treatment rises goblet cell counts but in the meantime elevates the intra ocular pressure and elevates the risk for infections. steroids that cause a lower increase in intraocular pressure have not been thoroughly evaluated in dry eye disease. we with to subjectively and objectively evaluate an FDA approved topical steroidal drug in the treatment of dry eye.

NCT ID: NCT02072122 Not yet recruiting - Dry Eye Syndromes Clinical Trials

Estrogen and the Outer Eye in Women During Fertility Treatment

Start date: March 2014
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of this study is to determine the relation between estrogen and progesterone levels, and between dryness of the eyes, in women during their fertile years.

NCT ID: NCT00718926 Not yet recruiting - Dry Eye Disease Clinical Trials

The Evaluation of Thiol Redox Status in Conjunctiva of Dry Eye Patients

Start date: August 2008
Phase: N/A
Study type: Observational

Dry eye disease is related with oxidative stress at the ocular surface. GSH is one of the key factor of protect from oxidative stress. To evaluate thiol status of ocular surface cells by monitoring GSH concentration, we can evaluate the severity of dry eye.